Connecticut: November Marijuana Sales Break Monthly Record

Legal marijuana sales in November set a new monthly record in Connecticut.

According to data released by the Connecticut Department of Consumer Protection, there was exactly $25,689,805.72 worth of legal marijuana and marijuana products sold throughout November. This breaks the monthly record of $25.2 million set in September of this year.

Of the nearly $25.7 million in marijuana sold, $15,372,542 came from the purchase of recreational marijuana, while $10,317,263 was purchased by authorized medical marijuana patients.
Continue reading

US Department of Health Spent Over 150 Pages Discussing Marijuana’s Potential Medical Value

 

The US Department of Health and Human Services (HHS) recently released an over 250-page document explaining their rationale for wanting marijuana rescheduled. Over 150 of these pages were spent discussing marijuana’s potential medical value, a key determinant in whether marijuana should be moved away from schedule I.

HHS released the documents last week to a pair of attorneys who requested them through the Freedom of Information Act (FOIA). The documents, which are heavily redacted, explain why the Department of Health sent a letter to the Drug Enforcement Agency (DEA) in September asking them to reschedule marijuana.

According to attorney Shane Pennington posting on the Substack On Drugs, “well over 150 pages” of the document was spent on the question of “whether marijuana has a currently accepted medical use in treatment in the United States.” This is important given that to be a schedule I drug, a substance must be dangerous, highly addictive and have no accepted medical value.
Continue reading

Colorado Made $22 Million in Marijuana Tax Revenue in November, a Quarter Billion Dollars Year-to-Date

For the sixth time this year, monthly marijuana tax revenue in Colorado was a little over $22 million.

In total the state garnered $22,125,036 in taxes from the legal distribution of marijuana and marijuana products, according to the Colorado Department of Revenue. This is on par with the $22.7 million sold in October and the $22.6 million sold in September. The high point for the year came in April (perhaps unsurprisingly), with $25.1 million.

Colorado’s year-to-date revenue for marijuana taxes is now $247 million. The total since the start of legal sales in 2014 is $2,599,068,573.
Continue reading

Report: CBD Market Valued at $7.6 Billion, to Grow to $36 Billion By 2033

 According to a new report, the global market for cannabidiol (CBD) was valued at $7.6 billion in 2023 and is anticipated to reach approximately $36.6 billion by 2033.

CBD tincture.

Over the period from 2024 to 2033, the CBD market is projected to experience a compound annual growth rate (CAGR) of 17.5%.

“CBD is renowned for its efficacy in pain alleviation, seizure management, and anxiety treatment”, states the report. “This has fueled a burgeoning demand for CBD in health and wellness sectors, propelling the market forward. Government approvals further contribute to the growing acceptance and utilization of CBD-infused products, fostering increased manufacturing to meet the rising consumer demand.”
Continue reading

US Congressmember Continues Pushing “Stop Pot Act” to Withhold Funds from Legal Marijuana States

North Carolina Congressmember Chuck Edwards continues to push the “Stop Pot Act” he filed in September, despite it gaining little traction thus far.

The Stop Pot Act would withhold federal funding from states and tribes that have legalized recreational marijuana. The measure is cosponsored by Representatives David Rouzer (NC), Gregory Murphy (NC), Pete Sessions (TX) and John Rose (TN), all Republican.

Despite receiving public backlash following the bill’s introduction, Representative Edwards is pushing forward with his effort to get the bill passed by the Republican-controlled House of Representatives. Recently his office began circulating a letter to congressional colleagues seeking additional cosponsors for the Stop Pot Act.
Continue reading

New Jersey Lowers Medical Marijuana Patient Enrollment Cost to Just $10 Every Two Years

New Jersey’s Cannabis Regulatory Commission (CRM) has announced that they have drastically decreased the cost of enrolling in the state’s medical marijuana program.

The CRM has announced that the cost to enroll in the medical marijuana program for a two-year period, and the cost to renew enrollment, has dropped from the previous price of $50, down to just $10. The change is effective immediately.

“Many patients face barriers to accessing treatment due to costs, like paying out of pocket for doctor’s visits and the cost of cannabis”, says Jeff Brown, Executive Director of the CRC. ” NJ-CRC is doing everything in our power to eliminate as many barriers as possible to ensure those who can benefit from cannabis treatment remain in the program”.
Continue reading

High Times Announces Winners of the 2023 New Mexico Cannabis Cup: People’s Choice Edition

High Times has announced the winners of the High Times Cannabis Cup New Mexico: People’s Choice Edition 2023, “representing the best cannabis the state has to offer.”

This year, the High Times Cannabis Cup New Mexico: People’s Choice Edition 2023 aired live and in-person at the Rio Rancho Events Center in Rio Rancho, near Albuquerque on Saturday, Dec. 9. This year featured 11 categories for a total of 33 products narrowed down as first, second, or third place winners for 2023.

“Many enter the competition, but few are chosen”, says High Times. “Each of these winners received an exclusive High Times trophy.”
Continue reading

Pennsylvania: Bipartisan Marijuana Decriminalization Bill to Be Filed Soon

A bipartisan pair of lawmakers in Pennsylvania have announced that they will soon be refiling legislation that would decriminalize the personal possession of marijuana.

Under the proposed law, introduced by Senators Sharif Street (D) and Camera Bartolotta (R), the personal possession of marijuana would become, at most, a $25 fine. Consuming marijuana in public would be a fine of up to $100.

Under current Pennsylvania law, even a miniscule amount of marijuana is a misdemeanor punishable by up to 30 days and jail and a driver’s license suspension of six month

Continue reading

Study: Cannabichromene (CBC) Has “Potential Anti-Inflammatory Effects”

The cannabis compound cannabichromene (CBD) “has potential anti-inflammatory effects and may be useful for preventing or treating inflammation”, according to a new study published in the journal Plants.

CBC is a widely unknown non-psychoactive cannabinoid found in marijuana. The compound has “recently been shown to possess several medicinal properties”, notes the abstract of the study. However, “how CBC produces anti-inflammatory effects and the mechanisms of this remain poorly studied.”

Therefore, researchers “extracted and purified the CBC from the Cannabis sativa cv. pink pepper”, and the “efficacy of CBC in reducing inflammation in RAW 264.7 macrophages and a λ-carrageenan-induced mouse model was then evaluated.”
Continue reading

Study Finds CBD May Improve Heart Regeneration Following Heart Attack

According to a new study, cannabidiol (CBD) “promotes cardiomyocyte proliferation and heart regeneration” following heart attacks.

Titled Cannabidiol represses miR-143 to promote cardiomyocyte proliferation and heart regeneration after myocardial infarction, the study is being publishing in the upcoming issue of the European Journal of Pharmacology, and it was published online ahead of print by the US National Library.

According to researchers, the study “was conducted to investigate the pharmacological effects of CBD on heart regeneration in post-myocardial infarction (MI) mice.”
Continue reading